STAAR exists to raise critical funds for life-saving research for those with low-grade ovarian cancer.
STAAR was co-founded by three low-grade ovarian cancer thrivers in early 2020. The foundation exists to fund research for better treatment options for low-grade serous carcinoma, a rare (less than 10% of ovarian cancer cases) and extremely underfunded subtype.
Low-grade serous carcinoma is often labeled as a "tricky opponent" by clinicians because it acts differently than more common subtypes - it grows slower and is often chemo-resistant, leaving fewer treatment options. The average age of diagnosis is 18 years younger than ovarian cancer overall, meaning that many diagnosed are young moms or never got a chance to have children. Research dedicated to low-grade ovarian cancer is desperately needed to give women a chance at longer lives.
For more information on low-grade serous carcinoma, please visit our friends at Cure Our Ovarian Cancer, the leading global charity dedicated to low-grade research.
Low-grade serous carcinoma is often labeled as a "tricky opponent" by clinicians because it acts differently than more common subtypes - it grows slower and is often chemo-resistant, leaving fewer treatment options. The average age of diagnosis is 18 years younger than ovarian cancer overall, meaning that many diagnosed are young moms or never got a chance to have children. Research dedicated to low-grade ovarian cancer is desperately needed to give women a chance at longer lives.
For more information on low-grade serous carcinoma, please visit our friends at Cure Our Ovarian Cancer, the leading global charity dedicated to low-grade research.
|
|
|
